Chemical Biology and Drug Design

JANUARY 25, 2025

N -substituted-5-([2,5-dihydroxybenzyl]-amino)salicylamides; 1 11 , exhibited invitro anticancer activity, with Compounds 4 , 5 , and 9 being most potent. COMPARE analysis showed polypharmacological multitargeting compounds. Compounds 4 , 5 , 9 11 displayed a remarkable EGFR-TK invitro inhibitory activity, induced apoptosis in NCI-H522 cell line, and showed predicted ADME pharmacokinetic profile.

Pharmacokinetics 100

Pharmacokinetics Trials Research 100

Drugs.com

JANUARY 25, 2025

SATURDAY, Jan. 25, 2025 In the throes of winter's yearly round of respiratory virus outbreaks, it pays to remember what Grandma told you.Wash your hands often, cover your nose and mouth with a tissue when you sneeze or cough and stay away from f.

Virus 246

Virus 246

Chemical Biology and Drug Design

JANUARY 25, 2025

Coumarin-3-carboxamide analogues were designed, synthesized, and evaluated for pancreatic lipase (PL) inhibition. Among the analogues, 5dh and 5de showed best PL inhibition, with IC 50 values of 9.20 and 11.4M, respectively, compared to Orlistat (IC 50 =0.97M). Analogue 5dh inhibited PL competitively with a K i of 4.504M. ABSTRACT A set of coumarin-3-carboxamide analogues were designed, synthesized, and evaluated for their ability to impede pancreatic lipase (PL) activity.

Research 100

Research 100